SCM
NKGNW

Shaolin Capital Management’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

Shaolin Capital Management’s Portfolio NKGNW Stock Details NKGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-65,515
Closed -$13K – 670
2023
Q2 		$13K Buy
+65,515
New +$11.5K ﹤0.01% 516

Other funds holding NKGNW

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
EAM
Exos Asset Management New York $2.32K AUM 108.13% 1-Year Est. Return
TCA
Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Shaolin Capital Management's NKGNW Position: Q4 2024 in Review

Shaolin Capital Management sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q4 2024, closing a stake of 128,274 shares — an estimated $9.07K sold.

Shaolin Capital Management first reported a position in NKGNW in Q3 2021 and held it in 12 quarters. The position peaked at $70K in Q4 2021. 26 funds tracked by Wall St. Rank hold NKGNW as of Q4 2024.

  • Shaolin Capital Management reported no remaining NKGen Biotech, Inc. Warrants position as of Q4 2024 after selling out during the quarter.
  • Shaolin Capital Management sold 128,274 NKGen Biotech, Inc. Warrants shares in Q4 2024, an estimated $9.07K.
  • Shaolin Capital Management first reported a position in NKGen Biotech, Inc. Warrants in Q3 2021 and held it in 12 quarters.
  • Shaolin Capital Management's NKGen Biotech, Inc. Warrants position peaked at $70K in Q4 2021.
  • 26 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q4 2024.

Based on Shaolin Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.